Clinical trial
Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study
NCT06592001 is registered in ClinicalTrials.gov with AtaCor Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study
- Lead sponsor
- AtaCor Medical, Inc.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 25, 2025
- Completion date
- December 31, 2028
- Enrollment
- 19 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
ventricular arrythmia, ventricular fibrillation, ventricular tachycardia